Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania

People living with HIV, even under therapy, have a high burden of age-related co-morbidities including an increased risk of dyslipidemia (which often predisposes to cardiovascular diseases) and immune-aging. In this study, lipid profiles and antibody responses to measles and pertussis toxin vaccines...

Full description

Bibliographic Details
Main Authors: Wilbert Mbuya, Issakwisa Mwakyula, Willyelimina Olomi, Peter Agrea, Francesco Nicoli, Cecilia Ngatunga, Leodegard Mujwahuzi, Paul Mwanyika, Mkunde Chachage
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.721747/full
_version_ 1818568616152399872
author Wilbert Mbuya
Issakwisa Mwakyula
Willyelimina Olomi
Peter Agrea
Francesco Nicoli
Cecilia Ngatunga
Leodegard Mujwahuzi
Paul Mwanyika
Mkunde Chachage
Mkunde Chachage
author_facet Wilbert Mbuya
Issakwisa Mwakyula
Willyelimina Olomi
Peter Agrea
Francesco Nicoli
Cecilia Ngatunga
Leodegard Mujwahuzi
Paul Mwanyika
Mkunde Chachage
Mkunde Chachage
author_sort Wilbert Mbuya
collection DOAJ
description People living with HIV, even under therapy, have a high burden of age-related co-morbidities including an increased risk of dyslipidemia (which often predisposes to cardiovascular diseases) and immune-aging. In this study, lipid profiles and antibody responses to measles and pertussis toxin vaccines were compared between ART experienced HIV+ children (n=64) aged 5-10 years, and their age- and sex-matched HIV- controls (n=47). Prevalence of high-density lipoprotein cholesterol (HDL-c) and triglyceride-driven dyslipidemia was higher among treated HIV+ children than in controls (51.6% vs 27.7% respectively, p < 0.019). In a multivariate Poisson regression model adjusted for age, sex and BMI, the association between low HDL-c, hypertriglyceridemia and HIV remained significantly high (for HDL-c: ARR: 0.89, 95% CI: 0.82 – 0.96, p = 0.003; for triglycerides: ARR: 1.54, 95% CI: 1.31 – 1.81, p < 0.001). Among HIV+ children, the use of lopinavir/ritonavir, a protease-based antiretroviral therapy was also associated elevation of triglyceride levels (p = 0.032). Also, HIV+ children had a 2.8-fold reduction of anti-measles IgG titers and 17.1-fold reduction of anti-pertussis toxin IgG levels when compared to HIV- children. Our findings suggest that dyslipidemia and inadequate vaccine-induced antibody responses observed in this population of young African HIV+ children might increase their risk for premature onset of cardiovascular illnesses and acquisition of preventable diseases.
first_indexed 2024-12-14T06:37:36Z
format Article
id doaj.art-51d62f4915c94322a6fe6ed4ab3f9b2a
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-14T06:37:36Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-51d62f4915c94322a6fe6ed4ab3f9b2a2022-12-21T23:13:19ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-11-011110.3389/fcimb.2021.721747721747Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in TanzaniaWilbert Mbuya0Issakwisa Mwakyula1Willyelimina Olomi2Peter Agrea3Francesco Nicoli4Cecilia Ngatunga5Leodegard Mujwahuzi6Paul Mwanyika7Mkunde Chachage8Mkunde Chachage9National Institute for Medical Research (NIMR), Mbeya Medical Research Centre (MMRC), Mbeya, TanzaniaDepartment of Internal Medicine, Mbeya Zonal Referral Hospital and University of Dar es Salaam Mbeya College of Health and Allied Sciences, Mbeya, TanzaniaNational Institute for Medical Research (NIMR), Mbeya Medical Research Centre (MMRC), Mbeya, TanzaniaNational Institute for Medical Research (NIMR), Mbeya Medical Research Centre (MMRC), Mbeya, TanzaniaDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, ItalyDepartment of Radiology, Mbeya Zonal Referral Hospital and University of Dar es Salaam Mbeya College of Health and Allied Sciences, Mbeya, TanzaniaDepartment of Internal Medicine, Mbeya Zonal Referral Hospital and University of Dar es Salaam Mbeya College of Health and Allied Sciences, Mbeya, TanzaniaDepartment of Paediatric, Mbeya Zonal Referral Hospital and University of Dar es Salaam Mbeya College of Health and Allied Sciences, Mbeya, TanzaniaNational Institute for Medical Research (NIMR), Mbeya Medical Research Centre (MMRC), Mbeya, TanzaniaDepartment of Microbiology and Immunology, University of Dar es Salaam - Mbeya College of Health and Allied Sciences (UDSM-MCHAS), Mbeya, TanzaniaPeople living with HIV, even under therapy, have a high burden of age-related co-morbidities including an increased risk of dyslipidemia (which often predisposes to cardiovascular diseases) and immune-aging. In this study, lipid profiles and antibody responses to measles and pertussis toxin vaccines were compared between ART experienced HIV+ children (n=64) aged 5-10 years, and their age- and sex-matched HIV- controls (n=47). Prevalence of high-density lipoprotein cholesterol (HDL-c) and triglyceride-driven dyslipidemia was higher among treated HIV+ children than in controls (51.6% vs 27.7% respectively, p < 0.019). In a multivariate Poisson regression model adjusted for age, sex and BMI, the association between low HDL-c, hypertriglyceridemia and HIV remained significantly high (for HDL-c: ARR: 0.89, 95% CI: 0.82 – 0.96, p = 0.003; for triglycerides: ARR: 1.54, 95% CI: 1.31 – 1.81, p < 0.001). Among HIV+ children, the use of lopinavir/ritonavir, a protease-based antiretroviral therapy was also associated elevation of triglyceride levels (p = 0.032). Also, HIV+ children had a 2.8-fold reduction of anti-measles IgG titers and 17.1-fold reduction of anti-pertussis toxin IgG levels when compared to HIV- children. Our findings suggest that dyslipidemia and inadequate vaccine-induced antibody responses observed in this population of young African HIV+ children might increase their risk for premature onset of cardiovascular illnesses and acquisition of preventable diseases.https://www.frontiersin.org/articles/10.3389/fcimb.2021.721747/fullHIVchildrendyslipidemiacardiovascular diseaseimmune senescencechildhood vaccines
spellingShingle Wilbert Mbuya
Issakwisa Mwakyula
Willyelimina Olomi
Peter Agrea
Francesco Nicoli
Cecilia Ngatunga
Leodegard Mujwahuzi
Paul Mwanyika
Mkunde Chachage
Mkunde Chachage
Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania
Frontiers in Cellular and Infection Microbiology
HIV
children
dyslipidemia
cardiovascular disease
immune senescence
childhood vaccines
title Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania
title_full Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania
title_fullStr Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania
title_full_unstemmed Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania
title_short Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania
title_sort altered lipid profiles and vaccine induced humoral responses in children living with hiv on antiretroviral therapy in tanzania
topic HIV
children
dyslipidemia
cardiovascular disease
immune senescence
childhood vaccines
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.721747/full
work_keys_str_mv AT wilbertmbuya alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT issakwisamwakyula alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT willyeliminaolomi alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT peteragrea alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT francesconicoli alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT ceciliangatunga alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT leodegardmujwahuzi alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT paulmwanyika alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT mkundechachage alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania
AT mkundechachage alteredlipidprofilesandvaccineinducedhumoralresponsesinchildrenlivingwithhivonantiretroviraltherapyintanzania